Healio
Researchers compared 22,694 first-time semaglutide users with 229,640 controls. Lead author Mille Dybdal Bager says the link shouldn't be read as cause and effect.
Recap by typeshit. Full story at Healio.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Lilly's 80-week phase 3 study of 1,152 adults, published in The Lancet, also showed HbA1c drops. Diarrhea and nausea were more common than on placebo.
Retatrutide is still in clinical trials, but PharmaVoice reports Lilly is already going after a network of illicit sellers offering it online.
Loading…